TITLE

Estrogen: A Novel Therapeutic Adjunct for the Treatment of Trauma-Hemorrhage--Induced Immunological Alterations

PUB. DATE
November 2008
SOURCE
Molecular Medicine;Nov/Dec2008, Vol. 14 Issue 11/12, p752
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article about the new therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations that was published in the March-April 2008 issue is presented.
ACCESSION #
35116455

 

Related Articles

  • New device stops bleeding faster.  // FDA Consumer;Jan/Feb96, Vol. 30 Issue 1, p2 

    Reports that the Vasoseal Vascular Hemostasis Device has received approval from the United States Food and Drug Administration. How device stops bleeding in angioplasty procedures; When the device was approved; How the device is used.

  • A memorable patient. Till, Kenneth // BMJ: British Medical Journal (International Edition);9/9/95, Vol. 311 Issue 7006, p681 

    Presents the author's recollection of using gauze to stop the bleeding of a patient on whose unprotected head had fallen a brick from a great height. Patient condition; Bleeding of the patient on removing the depressed bone; Recollection of George Grey Turner's recommendation for controlling...

  • Warfarin-based genotyping not cost effective for most patients.  // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p32 

    The article discusses research on the degree to which pharmacogenetic-guided dosing of warfarin improved risk for major bleeding compared to standard induction treatment with warfarin, published in the 2009 issue of the "Annals of Internal Medicine."

  • Prevention of Upper Gastrointestinal Bleeding. Peterson, Walter L. // New England Journal of Medicine;2/10/94, Vol. 330 Issue 6, p428 

    Editorial. Comments on an article by Jensen and his colleagues in the February 10, 1994 issue of the `New England Journal of Medicine.' Evidence that long-term maintenance therapy with histamine H2-receptor antagonists significantly reduces the incidence of recurrent bleeding in patients who...

  • 155-15. RESTART WARFARIN IN PATIENT WITH GI BLEEDING?  // Cortlandt Forum;01/25/2001, Vol. 14 Issue 1, p92 

    Answers a question about restarting warfarin therapy in an elderly black man who had experienced episodes of acute lower gastrointestinal (GI) bleeding. Success of previous anticoagulation with Coumadin; Risk of stroke in atrial fibrillation; Common reasons for not giving Coumadin in patients...

  • Halting hysterectomies.  // Herizons;Summer95, Vol. 9 Issue 2, p13 

    Reports that physicians in London, Ontario, have developed a procedure called uterine thermal balloon therapy which can be used to stop uterine bleeding and avoid unnecessary hysterectomies to some women.

  • Drugs in the News.  // Clarendon Enterprise (TX);2/26/2009, Vol. 20 Issue 9, p10 

    The article offers information on RiaSTAP, the first drug approved by the FDA for a person born with a rare deficiency of fibrinogen called Congenital Fibrinogen Deficiency.

  • ASK THE DOCTORS. Cho, Leslie; Grasso, Adam W. // Heart Advisor;Aug2014, Vol. 17 Issue 8, p8 

    The article presents questions and answers related to heart and cardiac care, the alternative drug to stop bleeding and the increase of blood pressure at night.

  • Warning leak in subarachnoid hemorrhage. Ostergaard, John R. // BMJ: British Medical Journal (International Edition);7/28/90, Vol. 301 Issue 6745, p190 

    Examines the diagnosis of aneurysmal subarachnoid hemorrhage. Symptoms of the disease; Clinical feature of the disease; Efficacy of the treatment for cerebral aneurysms.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics